| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Activation of cGAS-STING suppresses coxsackievirus replication via interferon-dependent signaling
|
Mohamud, Yasir
|
|
|
222 |
C |
p.
|
article
|
| 2 |
A flexible, image-based, high-throughput platform encompassing in-depth cell profiling to identify broad-spectrum coronavirus antivirals with limited off-target effects
|
Doijen, Jordi
|
|
|
222 |
C |
p.
|
article
|
| 3 |
A molecular perspective for the development of antibodies against the human respiratory syncytial virus
|
Loaiza, Ricardo A.
|
|
|
222 |
C |
p.
|
article
|
| 4 |
An intranasally delivered ultra-conserved siRNA prophylactically represses SARS-CoV-2 infection in the lung and nasal cavity.
|
Idris, Adi
|
|
|
222 |
C |
p.
|
article
|
| 5 |
Assessment of the broad-spectrum host targeting antiviral efficacy of halofuginone hydrobromide in human airway, intestinal and brain organotypic models.
|
García-Rodríguez, Inés
|
|
|
222 |
C |
p.
|
article
|
| 6 |
Discovery of new antiviral agents through artificial intelligence: In vitro and in vivo results
|
Izmailyan, Roza
|
|
|
222 |
C |
p.
|
article
|
| 7 |
Editorial Board
|
|
|
|
222 |
C |
p.
|
article
|
| 8 |
Feline infectious peritonitis virus ORF7a is a virulence factor involved in inflammatory pathology in cats
|
Jiao, Zhe
|
|
|
222 |
C |
p.
|
article
|
| 9 |
Ganciclovir and maribavir cross-resistance revisited: Relative drug susceptibilities of canonical cytomegalovirus mutants
|
Chou, Sunwen
|
|
|
222 |
C |
p.
|
article
|
| 10 |
Generation and evaluation of protease inhibitor-resistant SARS-CoV-2 strains
|
Bouzidi, Hawa Sophia
|
|
|
222 |
C |
p.
|
article
|
| 11 |
HAND2 suppresses favipiravir efficacy in treatment of Borna disease virus infection
|
Teng, Da
|
|
|
222 |
C |
p.
|
article
|
| 12 |
High-throughput drug screen identifies calcium and calmodulin inhibitors that reduce JCPyV infection
|
Bond, Avery C.S.
|
|
|
222 |
C |
p.
|
article
|
| 13 |
Molecular mechanism of rhinovirus escape from the Pyrazolo[3,4-d]pyrimidine capsid-binding inhibitor OBR-5-340 via mutations distant from the binding pocket: Derivatives that brake resistance
|
Richter, Martina
|
|
|
222 |
C |
p.
|
article
|
| 14 |
Next-generation bNAbs for HIV-1 cure strategies
|
Schriek, A.I.
|
|
|
222 |
C |
p.
|
article
|
| 15 |
Oral USC-093, a novel homoserinamide analogue of the tyrosinamide (S)-HPMPA prodrug USC-087 has decreased nephrotoxicity while maintaining antiviral efficacy against human adenovirus infection of Syrian hamsters
|
Tollefson, Ann E.
|
|
|
222 |
C |
p.
|
article
|
| 16 |
Promises and challenges of single-domain antibodies to control influenza
|
Matthys, Arne
|
|
|
222 |
C |
p.
|
article
|
| 17 |
PZR suppresses innate immune response to RNA viral infection by inhibiting MAVS activation in interferon signaling mediated by RIG-I and MDA5
|
Deng, Rilin
|
|
|
222 |
C |
p.
|
article
|
| 18 |
The absence of seroconversion after exposition to hepatitis C virus is not related to KIR-HLA genotype combinations (GEHEP-012 study)
|
Martín-Sierra, Carmen
|
|
|
222 |
C |
p.
|
article
|
| 19 |
TXM peptides inhibit SARS-CoV-2 infection, syncytia formation, and lower inflammatory consequences
|
Govednik, Tea
|
|
|
222 |
C |
p.
|
article
|
Journal description